Authors:
MOTZER RJ
MAZUMDAR M
GULATI SC
BAJORIN DF
LYN P
VLAMIS V
BOSL GJ
Citation: Rj. Motzer et al., PHASE-II TRIAL OF HIGH-DOSE CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUSBONE-MARROW TRANSPLANTATION IN 1ST-LINE THERAPY FOR PATIENTS WITH POOR-RISK GERM-CELL TUMORS, Journal of the National Cancer Institute, 85(22), 1993, pp. 1828-1835
Citation: J. Atzpodien et Sc. Gulati, T-CELLS AND MONOCYTES REGULATE THE GENERATION AND FUNCTIONAL-ACTIVITYOF NATURAL KILLER-DERIVED LYMPHOKINE-ACTIVATED KILLER-CELLS, Stem cells, 11(6), 1993, pp. 511-518
Citation: Rm. Lemoli et Sc. Gulati, EFFECT OF STEM-CELL FACTOR (C-KIT LIGAND), GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND INTERLEUKIN-3 ON HEMATOPOIETIC PROGENITORS IN HUMAN LONG-TERM BONE-MARROW CULTURES, Stem cells, 11(5), 1993, pp. 435-444
Citation: Sc. Gulati et L. Acaba, IMPROVING THE ROLE OF HEMATOPOIETIC SUPPORT FOR HIGH-DOSE CYTOTOXIC THERAPY, Cancer investigation, 11(3), 1993, pp. 319-326
Authors:
YAHALOM J
GULATI SC
TOIA M
MASLAK P
MCCARRON EG
OBRIEN JP
PORTLOCK CS
STRAUS DJ
PHILLIPS J
FUKS Z
Citation: J. Yahalom et al., ACCELERATED HYPERFRACTIONATED TOTAL-LYMPHOID IRRADIATION, HIGH-DOSE CHEMOTHERAPY, AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR REFRACTORYAND RELAPSING PATIENTS WITH HODGKINS-DISEASE, Journal of clinical oncology, 11(6), 1993, pp. 1062-1070
Authors:
LEMOLI RM
TAZZARI PL
FORTUNA A
BOLOGNESI A
GULATI SC
STIRPE F
TURA S
Citation: Rm. Lemoli et al., POSITIVE SELECTION OF HEMATOPOIETIC CD34-CELLS PROVIDES INDIRECT PURGING OF CD34-LYMPHOID CELLS AND INCREASES THE PURGING EFFICIENCY OF ANTI-CD2 AND ANTI-CD30 IMMUNOTOXINS( STEM), Experimental hematology, 21(8), 1993, pp. 1066-1066
Authors:
MOTZER RJ
GULATI SC
TONG WP
MENENDEZBOTET C
LYN P
MAZUMDAR M
VLAMIS V
LIN S
BOSL GJ
Citation: Rj. Motzer et al., PHASE-I TRIAL WITH PHARMACOKINETIC ANALYSES OF HIGH-DOSE CARBOPLATIN,ETOPOSIDE, AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH REFRACTORY GERM-CELL TUMORS, Cancer research, 53(16), 1993, pp. 3730-3735